Investment Q&A

• CryoPort Inc. (CYRX $8.11)
  • $8.11 P/E (TTM): 8.44X Cap: $404M
  • View CYRX Profile
  • View Questions on CYRX

Q: Hello Peter and team:

Do you have an opinion on this stock?

Regards
Rajiv

Upvote 0

Read Answer Asked by Rajiv on August 09, 2021

• Knight Therapeutics Inc. (GUD $6.35)
  • $6.35 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: I bought GUD as a long term investment. It worries me when you say you are losing patience with it and I suspect you will take it out of the portfolio if you find a very compelling replacement for that sector. But has anything fundamentally changed from when you included it in the portfiloio besides the time it is taking to spend the horde of cash?

Upvote 0

Read Answer Asked by Don on August 06, 2021

• Quipt Home Medical Corp. (QIPT $4.98)
  • $4.98 Cap: $220M
  • View QIPT Profile
  • View Questions on QIPT

Q: I am having difficulty making sense of the recent loss for this company. The results appear to be penalized by losses applying to a change in the fair value of debentures as well as derivatives which together are greater than the EBITDA earnings. I was wondering how relevant these are to the company's prospects and whether the resulting valuation justified the fall in the share price. Thank you for your response.

Upvote 0

Read Answer Asked by Mike on August 06, 2021

• BioCryst Pharmaceuticals Inc. (BCRX $9.51)
  • $9.51 P/E (TTM): 7.67X Cap: $2.29B
  • View BCRX Profile
  • View Questions on BCRX

Q: Goodday,

Can you comment on the strong earnings reported by BCRX today. Should I sell and take profits or do you think the stock will continue to improve favorably?
Thank you.

Upvote 0

Read Answer Asked by Karim on August 06, 2021

• Amedisys Inc (AMED)
  • P/E (TTM): 37.25X Cap: $3.32B
  • View AMED Profile
  • View Questions on AMED

Q: Hmm!.............what the heck happened today?

Upvote 0

Read Answer Asked by Roland on August 06, 2021

• AbCellera Biologics Inc. (ABCL $3.48)
  • $3.48 Cap: $1.03B
  • View ABCL Profile
  • View Questions on ABCL

Q: Hi, What s your opinion on ABCL?

Upvote 0

Read Answer Asked by francis on August 05, 2021

• Profound Medical Corp. (PRN $7.22)
  • $7.22 Cap: $227M
  • View PRN Profile
  • View Questions on PRN

Q: Any thoughts why the stock is moving downwards. I am still up 50 percent. Would you sell or hold. Thanks

Upvote 0

Read Answer Asked by Charles on August 05, 2021

• BioNTech SE (BNTX $88.06)
  • $88.06 Cap: $22.61B
  • View BNTX Profile
  • View Questions on BNTX

Q: Hi ...my favorite team on the planet. Happily I still own BNTX thanks to you. I have shaved a bit along the road., ..but this rise in price is astronomical. Do you think it can continue for a bit ?
much thanks as always!

Upvote 0

Read Answer Asked by El-ann on August 05, 2021

• Baxter International Inc. (BAX $16.47)
  • $16.47 Cap: $8.80B
  • View BAX Profile
  • View Questions on BAX

Q: How you review the recent quarter ended? The stock had 6% to 8% move between day high and low on Friday, the day it released quarter ended results. Any guess of such kind of moves.

Thanks
Piyush

Upvote 0

Read Answer Asked by Piyush on August 03, 2021

• Antibe Therapeutics Inc. (ATE $0.30)
  • View ATE Profile
  • View Questions on ATE

Q: Wow quite a rough day!
I bought as a spec at $5.00 in my TFSA. Should I B,S or H?

Upvote 0

Read Answer Asked by Tim on August 03, 2021

• Moderna Inc. (MRNA $51.82)
  • $51.82 Cap: $20.78B
  • View MRNA Profile
  • View Questions on MRNA

Q: Hi. what is your opinion Moderna MRNA
Thanks. Jean Guy

Upvote 0

Read Answer Asked by Jean Guy on August 03, 2021

• Illumina Inc. (ILMN $123.51)
  • $123.51 P/E (TTM): 22.09X Cap: $18.79B
  • View ILMN Profile
  • View Questions on ILMN
• Abbott Laboratories (ABT $108.06)
  • $108.06 P/E (TTM): 29.76X Cap: $188.95B
  • View ABT Profile
  • View Questions on ABT
• Guardant Health Inc. (GH $88.15)
  • $88.15 Cap: $11.44B
  • View GH Profile
  • View Questions on GH
• Fulgent Genetics Inc. (FLGT $15.36)
  • $15.36 Cap: $472M
  • View FLGT Profile
  • View Questions on FLGT

Q: Any companies that may benefit from the future of Covid as we learn to live with it Testing and therapeutics... not vaccine companies
Went for a wild ride with Flugent is it a option ? Others ?
Thanks
Greg

Upvote 0

Read Answer Asked by Greg on August 03, 2021

• MindBeacon Holdings Inc. (MBCN $3.45)
  • View MBCN Profile
  • View Questions on MBCN

Q: Hello
Could you comment on most recent quarterly earnings?

Thank you

Upvote 0

Read Answer Asked by Stephane on July 30, 2021

Q: Can you provide your insights into this company?

Upvote 0

Read Answer Asked by Denis on July 30, 2021

• Covalon Technologies Ltd. (COV $1.75)
  • $1.75 P/E (TTM): 59.67X Cap: $48M
  • View COV Profile
  • View Questions on COV
  • View Reports on COV

Q: Would you please comment on the recent sale of one of its product lines by Covalon. The market liked it in terms of share price, but where does that leave the company going forward. I own it, would you sell or hold at this time. Thanks.

Upvote 0

Read Answer Asked by Donald on July 30, 2021

• LifeSpeak Inc (LSPK $0.32)
  • $0.32 Cap: $18M
  • View LSPK Profile
  • View Questions on LSPK

Q: LifeSpeak ipo was priced at $10. It is now trading around $8.00. What is your opinion on this company?
I am thinking of taking a small position. Thanks

Upvote 0

Read Answer Asked by Joanne on July 30, 2021

• Knight Therapeutics Inc. (GUD $6.35)
  • $6.35 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: GUD seems awfully cheap at $5.05. Would you have any issues averaging down at this price? I see there was some insider buying fairly recently in the 5.25-5.30 range.

Upvote 0

Read Answer Asked by Edward on July 29, 2021

• Invitae Corporation (NVTA)
  • Cap: $5M
  • View NVTA Profile
  • View Questions on NVTA

Q: With declines from highs; is 5i/i2i actively increasing it's position in this stock? I have a small position in my us tfsa, looking to increase with a 3 to 5 year hold. In the medical genetics field, is there something about NVTA product lineup that gives it an edge over competitors?

Upvote 0

Read Answer Asked by Harry on July 29, 2021

• AbCellera Biologics Inc. (ABCL $3.48)
  • $3.48 Cap: $1.03B
  • View ABCL Profile
  • View Questions on ABCL

Q: Can I have your thoughts on this stock? Seem promising when it IPOed and has been on a slide since. Thank you.

Upvote 0

Read Answer Asked by ANDY on July 27, 2021

• Guardant Health Inc. (GH $88.15)
  • $88.15 Cap: $11.44B
  • View GH Profile
  • View Questions on GH

Q: Morning 5i Team,
Please comment on the significant pull back of GH over the last 6 months. Is it a hold, buy or sell now.
Thanks,
H

Upvote 0

Read Answer Asked by Harry on July 27, 2021